Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001615219-25-000105
Filing Date
2025-08-15
Accepted
2025-08-15 16:16:36
Documents
19

Document Format Files

Seq Description Document Type Size
1 S-3 slrx-formsx3atmprosupp2025.htm S-3 349610
2 salariuss3815.htm   iXBRL EX-FILING FEES 55358
3 EX-5.1 slrx-ex51opinion2025sx3.htm EX-5.1 23387
4 EX-23.1 ey-consentlanguagedrafttmp.htm EX-23.1 2616
5 EX-23.2 fruciauditconsent.htm EX-23.2 3182
6 image_0.jpg GRAPHIC 28105
7 image_0b.jpg GRAPHIC 14569
8 image_0c.jpg GRAPHIC 6145
9 image_1a.jpg GRAPHIC 53450
  Complete submission text file 0001615219-25-000105.txt   761659

Data Files

Seq Description Document Type Size
21 EXTRACTED XBRL INSTANCE DOCUMENT salariuss3815_htm.xml XML 21360
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-289646 | Film No.: 251224845
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)